CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
113
Frequently Asked Questions
What is Market Cap of Cg Oncology Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cg Oncology Inc. market cap is $3.1B.
What is the 52-week high for Cg Oncology Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cg Oncology Inc. 52 week high is $42.27 as of October 09, 2025.
What is the 52-week low for Cg Oncology Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cg Oncology Inc. 52 week low is $14.80 as of October 09, 2025.
What is Cg Oncology Inc. stock price today?
Cg Oncology Inc. stock price today is $41.53.
What was Cg Oncology Inc. stock price yesterday?
Cg Oncology Inc. stock price yesterday was $40.71.
What is the PE ratio of Cg Oncology Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cg Oncology Inc.’s P/E ratio is -24.22.
What is the Price-to-Book ratio of Cg Oncology Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cg Oncology Inc. P/B ratio is 4.6295.
What is the 50-day moving average of Cg Oncology Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cg Oncology Inc. 50-day moving average is $31.36.
